X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.85
Delayed Data
As of Feb 22
 -0.07 / -3.65%
Today’s Change
1.84
Today|||52-Week Range
4.14
-19.12%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.92
Today’s open1.90
Day’s range1.85 - 1.91
Volume6,238
Average volume (3 months)6,894
Market cap$9.9M
Data as of 1:51pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.05-7.88%
CYANCyanotech Corp+0.03+0.48%
IBIOIbio Inc+0.00+0.44%
ISRIsoRay Inc+0.01+1.33%
Data as of 8:00pm ET, 02/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts